1. Home
  2. BBCP vs RLMD Comparison

BBCP vs RLMD Comparison

Compare BBCP & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concrete Pumping Holdings Inc.

BBCP

Concrete Pumping Holdings Inc.

HOLD

Current Price

$6.43

Market Cap

333.0M

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$3.93

Market Cap

319.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBCP
RLMD
Founded
1983
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
333.0M
319.0M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
BBCP
RLMD
Price
$6.43
$3.93
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$7.50
$9.00
AVG Volume (30 Days)
139.3K
568.7K
Earning Date
03-10-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$392,867,000.00
N/A
Revenue This Year
$3.49
N/A
Revenue Next Year
$4.54
N/A
P/E Ratio
$72.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.78
$0.24
52 Week High
$8.05
$5.12

Technical Indicators

Market Signals
Indicator
BBCP
RLMD
Relative Strength Index (RSI) 48.85 42.66
Support Level $5.89 $3.22
Resistance Level $6.32 $3.93
Average True Range (ATR) 0.25 0.33
MACD 0.04 -0.03
Stochastic Oscillator 94.77 33.42

Price Performance

Historical Comparison
BBCP
RLMD

About BBCP Concrete Pumping Holdings Inc.

Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: